查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922704

日本药房零售市场规模、份额、趋势及预测（按市场结构、产品类型、治疗领域、药物类型、药房位置和地区划分），2026-2034年

Japan Pharmacy Retail Market Size, Share, Trends and Forecast by Market Structure, Product Type, Therapeutic Area, Drug Type, Pharmacy Location, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 120 Pages | 商品交期: 5-7个工作天内

价格
简介目录

日本零售药局市场在2025年达到1,206亿美元。 IMARC集团预测，到2034年，该市场规模将达到1,913亿美元，2026年至2034年的复合年增长率为5.26%。推动市场扩张的关键因素包括人口老化和慢性病增加、向医疗保健服务和数位化服务的转型、政府透过国民健康保险制度提供的支持，以及自动化和线上销售方面的技术进步。

日本药妆零售市场趋势：

人口老化和慢性病日益增多

日本零售药局市场成长要素之一是其快速老化的人口结构，这是全球老化速度最快的国家之一。截至2023年，65岁及以上人口的比例将超过28%，预计到2025年将超过30%。这项人口结构变化显着增加了对医疗保健服务和药局相关产品的需求。根据日本厚生劳动省的统计数据，65岁及以上人口中患有糖尿病、高血压和心血管疾病等慢性病的比例正在上升，导致处方药需求持续增加。老年消费者越来越依赖药局，不仅购买处方药，还购买非处方药、保健食品、进行健康咨询和获得预防保健服务。支撑这一趋势的是日本健全的国民健康保险（NHI）体系，该体系截至2023年覆盖了超过96%的人口，使包括医疗保健服务在内的各项医疗保健服务都变得便捷且价格合理。零售药局正在发展成为综合健康管理中心，提供宅配服务、用药咨询和针对老年消费者需求的先进药物管理。

技术创新与网路药局的发展

技术创新和线上药局的兴起正在重塑日本零售药局市场，并推动其显着成长。近年来，日本消费者越来越多地转向包括线上药局和健康应用程式在内的数位平台，以便更方便地获取药品和医疗保健服务。新冠疫情加速了这一数位转型，更多消费者选择远距医疗，并在线上订购处方药和非处方药。预计日本网路药局市场规模将在2024年达到64亿美元，并在2033年达到205亿美元。在数位健康技术创新和消费者对便利性日益增长的需求的推动下，预计2025年至2033年，该市场将以12.4%的复合年增长率成长。网路药局使消费者能够在家中订购药品、接收电子处方笺并获得远端医疗咨询。政府对数位医疗服务的支持，包括2023年推出的电子处方笺和线上咨询服务，进一步推动了这项转型。此外，实体药局的自动化和机器人技术，例如自动配药系统和机器人辅助操作，正在提高服务速度和准确性，缩短等待时间，并提升顾客满意度。

本报告解答的关键问题

  • 日本零售药局市场目前的表现如何？未来几年又将如何发展？
  • 根据市场结构，日本药局零售市场是如何分类的？
  • 日本药妆零售市场的产品类型组成是怎样的？
  • 日本药局零售市场依治疗领域分類的组成是怎样的？
  • 日本零售药局市场依药品类型分類的组成是怎样的？
  • 日本药局零售市场是如何根据药局位置进行细分的？
  • 日本药局零售市场按地区分類的情况如何？
  • 请介绍日本药局零售市场价值链的各个环节。
  • 日本药局零售市场的主要驱动因素和挑战是什么？
  • 日本药局零售市场的结构是怎么样的？主要参与者有哪些？
  • 日本药局零售市场的竞争程度如何？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本零售药局市场－引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本药局零售市场概述

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章 日本药局零售市场－市场结构分析

  • 杂乱无章
  • 组织

7. 日本药妆零售市场－依产品类型细分

  • 非处方药
  • 处方药
  • 非药品
  • 医疗设备

第八章：日本零售药局市场－依治疗领域划分

  • 循环系统
  • 止痛药/止痛剂
  • 维生素、矿物质和营养补充剂
  • 抗感染剂
  • 抗糖尿病药物
  • 其他的

第九章：日本零售药局市场－依药品类型划分

  • 学名药
  • 专利药品

第十章：日本零售药局市场－依药局位置划分

  • 商店类型/购物中心类型
  • 医院药房

第十一章：日本药局零售市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十二章：日本零售药局市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十三章主要企业概况

第十四章：日本药局零售市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十五章附录

简介目录
Product Code: SR112026A35683

The Japan pharmacy retail market size reached USD 120.6 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 191.3 Billion by 2034 , exhibiting a growth rate (CAGR) of 5.26% during 2026-2034 . The aging population with increasing chronic conditions, a shift towards home healthcare and digital services, government support through national insurance programs, and technological advancements in automation and online sales are among the key factors contributing to the market expansion.

JAPAN PHARMACY RETAIL MARKET TRENDS:

Aging Population and Increase in Chronic Conditions

A major growth driver of Japan's pharmacy retail market is the country's rapidly aging population, one of the fastest-aging globally. As of 2023, over 28% of Japan's population was aged 65 or older, and this figure is expected to exceed 30% by 2025. This demographic shift is significantly increasing demand for healthcare services and pharmacy-related products. According to the Ministry of Health, Labor and Welfare, a growing share of adults aged 65 and above in Japan suffer from chronic conditions, such as diabetes, hypertension, and cardiovascular diseases, leading to a steady rise in prescription medication needs. Elderly consumers increasingly depend on pharmacies not only for prescriptions but also for over-the-counter drugs, wellness products, health consultations, and preventive care. Supporting this trend is Japan's robust National Health Insurance (NHI) system, which covered over 96% of the population in 2023, making healthcare, including pharmacy services, both accessible and affordable. Retail pharmacies are evolving into comprehensive health management hubs, offering home delivery, medication counseling, and advanced pharmaceutical care tailored to the needs of aging consumers.

To get more information on this market Request Sample

Technological Advancements and E-Pharmacy Growth

Technological advancements and the rise of e-pharmacies are also reshaping Japan's pharmacy retail market, driving substantial growth. In recent years, Japanese consumers have increasingly turned to digital platforms, including online pharmacies and health apps, to access medications and healthcare services more conveniently. This digital shift, accelerated by the COVID-19 pandemic, has seen more consumers opting for remote consultations and ordering prescription drugs and over the counter (OTC) products online. Japan's e-pharmacy market size reached USD 6.4 billion in 2024 and is expected to reach USD 20.5 billion by 2033, exhibiting a growth rate (CAGR) of 12.4% during 2025-2033, driven by innovations in digital health technologies and growing consumer demand for convenience. E-pharmacies enable consumers to order medications from home, receive digital prescriptions, and access telemedicine consultations. Government support for digital health services, including the introduction of digital prescriptions and online consultations in 2023, has further fueled this transition. Additionally, automation and robotics in physical pharmacies, such as automated dispensing systems and robot-assisted operations, have improved service speed and accuracy, reduced wait times, and enhanced customer satisfaction.

JAPAN PHARMACY RETAIL MARKET SEGMENTATION:

Market Structure Insights:

  • Unorganized
  • Organized
  • Unorganized
  • Organized

Product Type Insights:

  • Access the comprehensive market breakdown Request Sample
  • Over-the-Counter Products
  • Prescribed Drugs
  • Non-Pharmaceutical Products
  • Medical Equipment
  • Over-the-Counter Products
  • Prescribed Drugs
  • Non-Pharmaceutical Products
  • Medical Equipment

Therapeutic Area Insights:

  • Cardiovascular
  • Pain Relief/Analgesics
  • Vitamins/Minerals/Nutrients
  • Anti-Infective
  • Anti-Diabetic
  • Others
  • Cardiovascular
  • Pain Relief/Analgesics
  • Vitamins/Minerals/Nutrients
  • Anti-Infective
  • Anti-Diabetic
  • Others

Drug Type Insights:

  • Generic
  • Patented
  • Generic
  • Patented

Pharmacy Location Insights:

  • Street/Mall Based
  • Hospital Based
  • Street/Mall Based
  • Hospital Based

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan pharmacy retail market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan pharmacy retail market on the basis of market structure?
  • What is the breakup of the Japan pharmacy retail market on the basis of product type?
  • What is the breakup of the Japan pharmacy retail market on the basis of therapeutic area?
  • What is the breakup of the Japan pharmacy retail market on the basis of drug type?
  • What is the breakup of the Japan pharmacy retail market on the basis of pharmacy location?
  • What is the breakup of the Japan pharmacy retail market on the basis of region?
  • What are the various stages in the value chain of the Japan pharmacy retail market?
  • What are the key driving factors and challenges in the Japan pharmacy retail market?
  • What is the structure of the Japan pharmacy retail market and who are the key players?
  • What is the degree of competition in the Japan pharmacy retail market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmacy Retail Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmacy Retail Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Pharmacy Retail Market - Breakup by Market Structure

  • 6.1 Unorganized
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Organized
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)

7 Japan Pharmacy Retail Market - Breakup by Product Type

  • 7.1 Over-the-Counter Products
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Prescribed Drugs
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Non-Pharmaceutical Products
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Medical Equipment
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)

8 Japan Pharmacy Retail Market - Breakup by Therapeutic Area

  • 8.1 Cardiovascular
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Pain Relief/Analgesics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Vitamins/Minerals/Nutrients
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Anti-Infective
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Anti-Diabetic
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2020-2025)
    • 8.6.2 Market Forecast (2026-2034)

9 Japan Pharmacy Retail Market - Breakup by Drug Type

  • 9.1 Generic
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Patented
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)

10 Japan Pharmacy Retail Market - Breakup by Pharmacy Location

  • 10.1 Street/Mall Based
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Hospital Based
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)

11 Japan Pharmacy Retail Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Market Structure
    • 11.1.4 Market Breakup by Product Type
    • 11.1.5 Market Breakup by Therapeutic Area
    • 11.1.6 Market Breakup by Drug Type
    • 11.1.7 Market Breakup by Pharmacy Location
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kansai/Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Market Structure
    • 11.2.4 Market Breakup by Product Type
    • 11.2.5 Market Breakup by Therapeutic Area
    • 11.2.6 Market Breakup by Drug Type
    • 11.2.7 Market Breakup by Pharmacy Location
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/ Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Market Structure
    • 11.3.4 Market Breakup by Product Type
    • 11.3.5 Market Breakup by Therapeutic Area
    • 11.3.6 Market Breakup by Drug Type
    • 11.3.7 Market Breakup by Pharmacy Location
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Market Structure
    • 11.4.4 Market Breakup by Product Type
    • 11.4.5 Market Breakup by Therapeutic Area
    • 11.4.6 Market Breakup by Drug Type
    • 11.4.7 Market Breakup by Pharmacy Location
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Market Structure
    • 11.5.4 Market Breakup by Product Type
    • 11.5.5 Market Breakup by Therapeutic Area
    • 11.5.6 Market Breakup by Drug Type
    • 11.5.7 Market Breakup by Pharmacy Location
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Market Structure
    • 11.6.4 Market Breakup by Product Type
    • 11.6.5 Market Breakup by Therapeutic Area
    • 11.6.6 Market Breakup by Drug Type
    • 11.6.7 Market Breakup by Pharmacy Location
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Market Structure
    • 11.7.4 Market Breakup by Product Type
    • 11.7.5 Market Breakup by Therapeutic Area
    • 11.7.6 Market Breakup by Drug Type
    • 11.7.7 Market Breakup by Pharmacy Location
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Market Structure
    • 11.8.4 Market Breakup by Product Type
    • 11.8.5 Market Breakup by Therapeutic Area
    • 11.8.6 Market Breakup by Drug Type
    • 11.8.7 Market Breakup by Pharmacy Location
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan Pharmacy Retail Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Services Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Services Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Services Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Services Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Services Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Pharmacy Retail Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix